Healthcare perspectives from The Economist Intelligence Unit

Color

#DB444B

Hero Carousel

Spotlight

Bringing healthcare to hard-hit areas in Bangladesh

YouTube

https://www.youtube.com/channel/UCQDMOSbJtqrtNzif5rS22OQ

Slideshare

http://www.slideshare.net/economistintelligenceunit

Pinterest

https://www.pinterest.com/theeiu/

Examining the policy response to vascular disease: The example of peripheral arterial disease

While cardiac diseases such as coronary artery disease (CAD), including heart attack and stroke, are widely understood, many vascular diseases—those affecting blood vessels outside the heart, including arteries and veins supplying all other equally vital organs—are comparatively less well understood by the public and policymakers. These peripheral diseases are a major cause of morbidity, and it is now known that arterial disease outside the heart is a powerful predictor of heart attack and stroke.

Reducing the burden: The economic and social costs of lung cancer in Italy - Infographic Pt.1

Confronting obesity in the United Arab Emirates

Although the United Arab Emirates (UAE) has managed to defeat many of the infectious diseases that still affect other parts of the region, obesity and associated non-communicable diseases (NCDs) remain a major issue. 

Confronting obesity in the Middle East: Cultural, social and policy challenges

A combination of major lifestyle and dietary changes over the past few decades, harsh weather conditions that limit outdoor activities and a genetic predisposition has led to an obesity crisis in many parts of the Middle East, especially in the Gulf Co- operation Council (GCC) states of Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and the United Arab Emirates (UAE).

This report is based on five in-depth interviews with senior obesity experts from the region, complemented by extensive desk research. The main findings of the research are as follows.

Confronting obesity in the Middle East: Cultural, social and policy challenges

This report is based on five in-depth interviews with senior obesity experts from the region, complemented by extensive desk research. The main findings of the research are as follows: 

Fighting cancer with artificial intelligence

AI systems are already being used both to diagnose cancer and to develop new treatments

Reducing the burden: The economic and social costs of lung cancer in Italy

Reducing the burden: The economic and social costs of lung cancer in Italy presents the results of this research. This white paper was written by The Economist Intelligence Unit (EIU) and sponsored by Roche. It is based on desk research and in-depth interviews with 15 experts in the topic.

Reducing the burden: The economic and social costs of lung cancer in Italy

The incidence of lung cancer is rising in Italy, particularly among women. On the other hand Italy, like many of its European neighbours, is improving the ways that it fights lung cancern, both in a clinical sense and through an array of broader policies. By considering a variety of measures to discourage smoking, and by experimenting with innovative approaches to financing new treatments, Italy is starting to formulate plans to reduce the burdens of the disease.

Tackling tuberculosis in South Africa: Building on the political momentum

As a relatively wealthy African country and one of the BRICS nations (Brazil, Russia, India, China and South Africa), South Africa has been able to make more substantial investments in combating tuberculosis (TB) and multi-drug-resistant tuberculosis (MDR TB) than many others in the region. This, combined with strong political will, has put South Africa ahead of many of its peers in the fight against the disease.

 

Tackling tuberculosis in Nigeria: Funding gaps and fragmentation

For Nigeria, the barriers to tackling multidrug-resistant tuberculosis (MDR TB) include external factors such as the Boko Haram insurgency (which is also hampering the battle against polio). However, persistent weaknesses in the country’s health system that are lowering its diagnosis and treatment capacity are also contributing to Nigeria’s struggle to control tuberculosis (TB) and MDR TB.

 

Enjoy in-depth insights and expert analysis - subscribe to our Perspectives newsletter, delivered every week